ReviewBiomimetics (Basel, Switzerland)2026
Biomechanical Properties of Silk-Derived 3D Bioprinted Scaffolds for Cartilage Regeneration: A Comprehensive Review.
Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cartilage regeneration remains a major clinical challenge because cartilage has limited healing capacity and must withstand substantial mechanical loading. Silk fibroin, a cocoon-derived biomaterial with tunable mechanical properties, has emerged as a promising scaffold material for cartilage tissue engineering. This systematic review evaluates the biomechanical performance, fabrication approaches, and regenerative potential of silk fibroin bioprinted scaffolds for cartilage repair. A systematic review was conducted according to PRISMA guidelines. Primary outcomes included scaffold mechanical properties relevant to cartilage function. Secondary outcomes included scaffold composition, fabrication methods, biological performance, clinical applications, and reported limitations. Of 918 identified records, 24 studies published between 2014 and 2025 met the inclusion criteria. Most were preclinical studies using silk fibroin-based hydrogels, often combined with hyaluronic acid, gelatin, collagen, or synthetic polymers. Mechanical properties varied according to scaffold composition and crosslinking methods. Reinforced scaffolds generally demonstrated improved stiffness, structural support, and load distribution. Silk fibroin scaffolds consistently supported chondrogenesis and cartilage-like tissue formation. However, challenges remain, including mechanical mismatch with native cartilage, construct instability, cell loss, and suboptimal degradation profiles. Overall, silk fibroin bioprinted scaffolds demonstrated support for chondrogenesis and cartilage-like tissue formation in preclinical studies for cartilage regeneration. Future research should focus on standardized biomechanical testing, long-term in vivo evaluation, and clinically relevant scaffold designs to facilitate translation toward functional cartilage repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.